Deutsche Bank Provides $25MM in Debt Financing to Cycle Pharmaceuticals
Cycle Pharmaceuticals, a privately-owned biotechnology company focused on developing and delivering medicines for rare diseases, executed a definitive agreement for a $25 million credit facility with Deutsche Bank.
September 8, 2020
Antonio Benedetti | Cycle Pharmaceuticals | Deutsche Bank AG | Dimitrios Weedon | Varsity Pharmaceuticals
Phil Neuffer